APA (7th ed.) Citation

LP, L., M, N., A, M., J, M., M, D., E, P., & C, P. (2026). High-Grade Immune-Related Adverse Events Resulting from Immune Checkpoint Inhibitor Treatment: Evaluation of Diagnostics and Outcomes in Admitted Patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 34(3), 222. https://doi.org/10.1007/s00520-026-10448-w

Chicago Style (17th ed.) Citation

LP, Legakis, Naagendran M, Matthews A, Morris J, Davies M, Prsic E, and Price C. "High-Grade Immune-Related Adverse Events Resulting from Immune Checkpoint Inhibitor Treatment: Evaluation of Diagnostics and Outcomes in Admitted Patients." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 34, no. 3 (2026): 222. https://doi.org/10.1007/s00520-026-10448-w.

MLA (9th ed.) Citation

LP, Legakis, et al. "High-Grade Immune-Related Adverse Events Resulting from Immune Checkpoint Inhibitor Treatment: Evaluation of Diagnostics and Outcomes in Admitted Patients." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer, vol. 34, no. 3, 2026, p. 222, https://doi.org/10.1007/s00520-026-10448-w.